1,087.00 USD
↗ 22.85 (2.15%)LIVE (AS OF 12:41 PM EDT)
Open?$1,059.50
High?$1,088.41
Low?$1,054.58
Prev. Close?$1,064.15
Volume?993.3K
Avg. Volume?3.4M
VWAP?$1,077.48
Rel. Volume?0.29x
Bid / Ask
Bid?$1,086.21 × 80
Ask?$1,086.98 × 80
Spread?$0.77
Midpoint?$1,086.60
Valuation & Ratios
Market Cap?948.9B
Shares Out?941.7M
Float?851.3M
Float %?90.1%
P/E Ratio?37.54
P/B Ratio?30.42
EPS?$28.35
Dividend?0.59%
Ex-Dividend?N/A
Shares of Eli Lilly & Co. (LLY) are trading at $1,087.00. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (81.0%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 2, 2026.
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
965.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?79
Piotroski F-Score?6/9Mixed
Altman Z-Score?8.72Safe
Confidence?80%High
Short InterestLow
Short % of Float?0.99%Low
Short Interest?8.4M
Days to Cover?2.5
Free Float851.3M
Avg Daily Volume3.3M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?37.5PRICEY▾
Peers20
S&P19
P/B?30.42HIGH▾
Peers10
S&P3
P/S?13.13HIGH▾
Peers20
S&P3
P/FCF?80.3PRICEY▾
Peers10
S&P3
EV/EBITDA?27.3HIGH▾
Peers20
S&P13
EV/Sales?13.66HIGH▾
Peers20
S&P5
Returns & Efficiency
ROE?81.0%STRONG▾
Peers78
S&P97
ROA?21.7%STRONG▾
Peers90
S&P97
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$987.0B
Fundamentals ratios updated end of day